Marshall Wace, LLP Maravai Lifesciences Holdings, Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 394,012 shares of MRVI stock, worth $874,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
394,012
Previous 2,778,497
85.82%
Holding current value
$874,706
Previous $15.1 Million
94.25%
% of portfolio
0.0%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding MRVI
# of Institutions
208Shares Held
129MCall Options Held
267KPut Options Held
648K-
Gtcr LLC20.2MShares$44.7 Million4.99% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$27.8 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$25.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$21.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$18.5 Million1.13% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $292M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...